Zobrazeno 1 - 10
of 1 743
pro vyhledávání: '"D Cimino"'
Autor:
Paul T. Henderson, Chong-xian Pan, Ralph de Vere White, Karim Chamie, Alexandra Drakaki, Clifford G. Tepper, George D. Cimino, Kenneth W. Turteltaub, Susan Airhart, Hongyuan Yang, Ted Ognibene, Kurt Haack, Michael Malfatti, Tzu-yin Lin, Hongyong Zhang, Si-Si Wang, Maike Zimmermann
We report progress on predicting tumor response to platinum-based chemotherapy with a novel mass spectrometry approach. Fourteen bladder cancer patients were administered one diagnostic microdose each of [14C]carboplatin (1% of the therapeutic dose).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ecee25af3630876e71d2c645bb27963
https://doi.org/10.1158/1535-7163.c.6537576
https://doi.org/10.1158/1535-7163.c.6537576
Autor:
Paul T. Henderson, Chong-xian Pan, Ralph de Vere White, Karim Chamie, Alexandra Drakaki, Clifford G. Tepper, George D. Cimino, Kenneth W. Turteltaub, Susan Airhart, Hongyuan Yang, Ted Ognibene, Kurt Haack, Michael Malfatti, Tzu-yin Lin, Hongyong Zhang, Si-Si Wang, Maike Zimmermann
Chemical structures, patient data, mouse survival curves, additional biomarker data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2764d3d1fe8d481eae79211b415ae1fa
https://doi.org/10.1158/1535-7163.22503975.v1
https://doi.org/10.1158/1535-7163.22503975.v1
Autor:
Michael A. Malfatti, Bruce A. Buchholz, Heather A. Enright, Benjamin J. Stewart, Ted J. Ognibene, A. Daniel McCartt, Gabriela G. Loots, Maike Zimmermann, Tiffany M. Scharadin, George D. Cimino, Brian A. Jonas, Chong-Xian Pan, Graham Bench, Paul T. Henderson, Kenneth W. Turteltaub
Publikováno v:
Toxics, Vol 7, Iss 2, p 27 (2019)
This review summarizes recent developments in radiocarbon tracer technology and applications. Technologies covered include accelerator mass spectrometry (AMS), including conversion of samples to graphite, and rapid combustion to carbon dioxide to ena
Externí odkaz:
https://doaj.org/article/28a1dab6fc984ce8bc5a6cc1f8003aa6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Michael A. Malfatti, Paul T. Henderson, Kenneth W. Turteltaub, Chun Yi Wu, Thomas J. Semrad, Aiming Yu, George D. Cimino, Maike Zimmermann, May Cho, Kurt W. Haack, Tao Li, Chong-Xian Pan, Edward J. Kim
Publikováno v:
Molecular cancer therapeutics, vol 19, iss 4
Mol Cancer Ther
Mol Cancer Ther
FOLFOX is one of the most effective treatments for advanced colorectal cancer. However, cumulative oxaliplatin neurotoxicity often results in halting the therapy. Oxaliplatin functions predominantly via the formation of toxic covalent drug–DNA addu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82b0b2f3379dd9e7a2370c5d90844d70
https://escholarship.org/uc/item/3v16z9qs
https://escholarship.org/uc/item/3v16z9qs
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance The reporting of suspected adverse drug reactions (ADRs) in the National Pharmacovigilance Network (NPN) in our country can be done by different professionals (doctor, lawyer, pharmacist, nurse, health worker, etc) or by the
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance Underreporting in oncology practice is a known phenomenon linked to the predictable toxicity of these drugs. Reporting indicators are often calculated on very large catchment areas and this limits the capacity for self-asses
Publikováno v:
The Reading Teacher. 72:485-498
Autor:
S. Wang, Tzu-yin Lin, Maike Zimmermann, Chong-Xian Pan, Ralph de Vere White, Kurt W. Haack, Michael A. Malfatti, Hongyong Zhang, Paul T. Henderson, Kenneth W. Turteltaub, George D. Cimino
Publikováno v:
International Journal of Cancer. 141:604-613
The platinum-based drugs cisplatin, carboplatin and oxaliplatin are often used for chemotherapy, but drug resistance is common. The prediction of resistance to these drugs via genomics is a challenging problem since hundreds of genes are involved. A